WuXi AppTec acquires US-based CRO noting recent Chinese regulatory reforms

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/psisa)
(Image: Getty/psisa)

Related tags: Wuxi apptec, Clinical trial

WuXi AppTec’s acquisition of ResearchPoint Global (RPG) follows the release of a new guideline that will enable Chinese companies to accept clinical trial data from other countries.

The guideline was issued last week​ in a move to reform the management of clinical trials in the country.

WuXi cited the recent regulatory changes in its announcement of the acquisition, noting the opportunities presented by the reform.

According to the company, the acquisition is a strategic step forward to expand its clinical research capabilities in the US and globally.

The Austin, Texas-headquartered contract clinical research organization will operate as a wholly-owned subsidiary of WuXi. WuXi’s China-based Clinical Development Service (CDS) team will be integrated into the new business unit.

Dr. Ge Li WuXi AppTec chairman and CEO commented in a press release: "This business combination lays the groundwork for the creation of an integrated global clinical service organization with global expertise and global network."

Related news

Show more

Related products

show more

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Related suppliers

Follow us

Products

View more